## ULTA: Ulta Beauty, Inc. - XLY: Consumer Cyclical

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 9.8% in upper entry zone (4.0-10.0%), top 5% cross-sectional ranking. Short-term MRS_5 (2.0%) confirms momentum alignment. Strong momentum (+1.2% 5-day acceleration). Outperforming sector by 6.8%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($561.67)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. What Ulta Beauty (ULTA)'s Upgraded 2025 Outlook and Loyalty Momentum Means For Shareholders**
- Source: Simply Wall Street | 20251214T050844 | Somewhat-Bullish | Relevance: 100%
- Ulta Beauty has reported strong third-quarter sales, raising its full-year 2025 guidance for net sales, operating margin, and EPS. This upgraded outlook is driven by robust sales growth, record loyalty engagement, and exclusive brand launches, reinforcing confidence in the company's operating model. The article discusses what this means for shareholders, the investment narrative, and potential risks like rising costs impacting margins.

**2. What Ulta Beauty (ULTA)'s Upgraded 2025 Outlook and Loyalty Momentum Means For Shareholders**
- Source: Simply Wall Street | 20251214T044127 | Bullish | Relevance: 100%
- Ulta Beauty recently reported strong third-quarter results and upgraded its full-year 2025 guidance, citing strong sales growth, record loyalty engagement, and exclusive brand launches. While this increased confidence in the company's operating model, investors should also consider the potential long-term pressures on profitability from rising costs in stores, wages, and benefits. Ultaâ€™s narrative projects significant revenue and earnings growth by 2028, with a fair value estimate in line with its current price.

**3. Ulta Beauty Counters Rivals With Advantages in Product Selection, Stores, and Loyalty**
- Source: Morningstar | 20251210T220834 | Bullish | Relevance: 100%
- Ulta Beauty maintains a narrow economic moat through its strong brand, extensive product selection, and a successful loyalty program with over 45 million members. The company has significantly increased its revenue and store count over the past decade, effectively competing against both mall-based retailers and e-commerce giants like Amazon. Ulta's strategy leverages in-store experiences, salons, and promotions to encourage frequent customer visits and drive market share.

**4. Herbivore Debuts Exclusive Bodycare Collection and Partnership with Ulta Beauty**
- Source: PR Newswire | 20251215T120157 | Bullish | Relevance: 100%
- Herbivore, the prestige, plant-powered beauty brand, has announced a new partnership with Ulta Beauty, launching a 15-piece Body Collection exclusively for the retailer. This collection will be available in over 850 stores nationwide starting December 28, 2025, and online from December 21, 2025. This initiative, led by CEO Britany LeBlanc, marks a significant expansion for Herbivore into the bodycare category, leveraging Ulta Beauty's extensive reach to introduce plant-powered formulations to a wider audience.

**5. Major cosmetics chain bringing second location to Rio Norte Shopping Center**
- Source: Laredo Morning Times | 20251214T130903 | Bullish | Relevance: 100%
- Ulta Beauty is set to open its second Laredo location in 2026 at the Rio Norte Shopping Center. The new 12,048-square-foot store, valued at an estimated $761,000 for renovation, will be situated at 5410 San Bernardo Ave., Suite 60. Construction is slated to begin in early March and conclude in May, with Robert G. Lyon & Associates leading the project.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 13, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Oppenheimer | $675 | $615 | +10% |
| 2025-12-08 | Morgan Stanley | $640 | $600 | +7% |
| 2025-12-08 | TD Cowen | $725 | $600 | +21% |
| 2025-12-05 | DA Davidson | $650 | $625 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Oppenheimer | main | Outperform |
| 2025-12-08 | Morgan Stanley | main | Overweight |
| 2025-12-08 | TD Cowen | up | Buy |
| 2025-12-05 | DA Davidson | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+0.6%)
- Blackrock Inc.: 9.0% (-2.1%)
- JPMORGAN CHASE & CO: 5.5% (+99.0%)
- State Street Corpora: 4.4% (+2.3%)
- Sanders Capital, LLC: 2.8% (+8.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 13 raises (avg +6%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.52 signals overvaluation risk, limited margin of safety. Forward P/E 21.3x stretched relative to 11% growth. Quality metrics strong (ROE 48%, ROA 15%). Analyst sentiment positive (13 raises, avg +6%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.0B |
| Beta | 0.87 |
| 52W Range | $309.01 - $611.90 |
| Short Interest | 6.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.52 |
| Forward P/E | 21.3 |
| Current P/E | 23.6 |
| YoY Growth | 10.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 8.6% to 9.8% (+1.2% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 94th percentile. MRS_5 at 2.0% confirms short-term momentum alignment. AM_20 at 10.1% shows strong absolute momentum above own 20MA. Outperforming sector by 6.8pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (7.37), confirming momentum. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 9.77% (CS: 95) | Strong |
| RSI_14 | 68.2 | Neutral |
| MACD Histogram | 7.37 | Bullish |
| vs SMA20 | 1.101x | Above |
| vs SMA50 | 1.120x | Above |
| vs SMA200 | 1.278x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $601.59
- **Stop Loss:** $561.67 (6.6% risk)
- **Target:** $661.47 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 30
- **Position Value:** $18,047.70
- **Portfolio %:** 18.05%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-03-12 (Est: $7.15)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.60 | $5.14 | +11.8% |
| 2025Q3 | $5.04 | $5.78 | +14.6% |
| 2025Q2 | $5.80 | $6.70 | +15.5% |
| 2025Q1 | $7.15 | $8.46 | +18.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*